Gregory D. Gorgas insider trades

Open-market stock purchases and sales by Gregory D. Gorgas, Pres, CEO, CFO, Treas & Secr at Artelo Biosciences, Inc, from SEC Form 4 filings since Jul 21, 2011.

Track record: 75% of 12 scored buys are up 5% or more since purchase, averaging +26%.

Recent trades

DateStockTradeValue
Jan 29, 2026ARTL Artelo Biosciences, IncBought (not open market)—
Oct 28, 2025ARTL Artelo Biosciences, IncBought (not open market)$59.8K
Oct 28, 2025ARTL Artelo Biosciences, IncBought (not open market)$61K
Oct 28, 2025ARTL Artelo Biosciences, IncBought (not open market)—

Companies traded

  • ARTL Artelo Biosciences, Inc: 13 buys, last Jan 29, 2026
  • MSTX Mast Therapeutics, Inc: other filings, last Jan 4, 2016
  • ANX Adventrx Pharmaceuticals Inc: other filings, last Jan 2, 2013

Get free alerts when Gregory D. Gorgas files a new trade →